Can you create a brief summary for an asymptomatic patient with grade 1 left‑ventricular diastolic dysfunction, normal left‑atrial volume index (21 mL/m²), resting early mitral inflow velocity to early diastolic mitral annular velocity (E/e′) 9.2, and no evidence of heart‑failure with preserved ejection fraction, to present to physicians at a cardiovascular center?

Patient Summary for Cardiovascular Center Consultation

Clinical Profile

This patient is asymptomatic with grade 1 left-ventricular diastolic dysfunction and does not meet criteria for heart failure with preserved ejection fraction (HFpEF).

The patient presents with:

• Grade 1 diastolic dysfunction (mild impairment of left ventricular relaxation) 1
• Normal left atrial volume index of 21 mL/m² (well below the 34 mL/m² threshold associated with HFpEF) 2
• Normal E/e′ ratio of 9.2 (below the 14–15 threshold for elevated filling pressures) 1, 2
• No symptoms of heart failure (no dyspnea, fatigue, orthopnea, or reduced exercise tolerance) 1
• No clinical heart failure syndrome present 1

---

Why This Patient Does NOT Have HFpEF

Heart failure requires BOTH symptoms AND objective cardiac dysfunction; this patient has neither. 1

The diagnostic criteria for HFpEF mandate three elements 1:

1. Symptoms (dyspnea, fatigue, orthopnea, or exercise intolerance) — ABSENT in this patient
2. Preserved ejection fraction ≥50% — present
3. Evidence of elevated filling pressures demonstrated by E/e′ >14, left atrial enlargement (LAVI >34 mL/m²), or elevated natriuretic peptides — ABSENT in this patient 1, 2

The patient's LAVI of 21 mL/m² is markedly below the 34 mL/m² cut-off that identifies HFpEF with 90% specificity. 2 Similarly, the E/e′ of 9.2 falls well below the 15 threshold for elevated filling pressures. 2

---

ACC/AHA Staging Classification

This patient is ACC/AHA Stage B: structural heart disease without current or prior heart failure symptoms. 1

Stage B describes patients with cardiac structural abnormalities (in this case, grade 1 diastolic dysfunction) who have never experienced heart failure symptoms and do not meet criteria for clinical heart failure. 1 This stage carries increased cardiovascular risk compared to the general population but does not warrant heart failure therapy. 1

---

Prognostic Significance of Normal Left Atrial Parameters

The normal left atrial volume index is particularly reassuring and argues strongly against clinically significant diastolic disease. 2, 3

• LAVI is the single most powerful echocardiographic parameter for identifying HFpEF, with an area under the curve of 0.90 in validation studies 2
• Maximum left atrial volume reflects the chronicity and severity of diastolic dysfunction; a normal LAVI indicates the left ventricle has not imposed sustained pressure burden on the atrium 3
• Left atrial enlargement (LAVI >34 mL/m²) precedes symptoms in progressive diastolic disease, so its absence suggests early or non-progressive dysfunction 3
• In patients with sinus rhythm, LAVI is the single significant factor associated with diastolic dysfunction in multivariable analysis (AUC 83%) 4

The E/e′ ratio of 9.2 confirms normal left ventricular filling pressures at rest. 1 An E/e′ <14 effectively excludes elevated filling pressures and is inconsistent with symptomatic HFpEF. 1, 2

---

Clinical Implications and Natural History

Grade 1 diastolic dysfunction in an asymptomatic patient represents the earliest phase of a continuum that may or may not progress. 5

• The process of cardiac remodeling generally precedes symptoms by months or years, and many patients with mild diastolic abnormalities remain asymptomatic indefinitely 5
• Patients with very low ejection fraction may be asymptomatic, whereas those with preserved systolic function may have severe disability—the apparent discordance between structural findings and functional impairment is not well understood 5
• Left ventricular dysfunction is usually progressive, even without new identifiable insults, but the rate of progression varies widely 5

---

Recommended Management Approach

This patient requires surveillance rather than treatment. 6

Monitoring Schedule

• Clinical follow-up every 6–12 months to assess for development of symptoms (dyspnea, fatigue, exercise intolerance, orthopnea) 6
• Echocardiography every 12 months to monitor left ventricular size, function, and left atrial volume 6

Activity and Lifestyle

• Regular physical activity is beneficial and should be encouraged; moderate aerobic exercise is recommended 6
• Normal daily activities and work can continue without restrictions as long as the patient remains asymptomatic 6
• Maintain optimal blood pressure control and consider moderate sodium restriction 6

Warning Signs to Report

• Development of exertional dyspnea, fatigue, or reduced exercise tolerance 6
• Symptoms of volume overload including orthopnea, paroxysmal nocturnal dyspnea, or peripheral edema 6

Medications to Avoid

• Avoid NSAIDs, certain calcium channel blockers (verapamil, diltiazem), and some antiarrhythmic drugs that can negatively affect left ventricular function 6

---

Key Pitfalls to Avoid

Do not initiate heart failure pharmacotherapy in the absence of symptoms and elevated filling pressures. 5

• Vasodilator therapy is not indicated for asymptomatic patients with mild diastolic dysfunction and normal LV systolic function (Class III recommendation) 5
• Heart failure is not synonymous with "structural heart disease"—a substantial proportion of patients with cardiac abnormalities never develop clinical heart failure 1
• The absence of peripheral edema does not exclude heart failure, but its presence does not confirm it; pitting edema lacks sufficient sensitivity and specificity to serve as a diagnostic marker 1

Women and smaller individuals may develop symptoms with less ventricular dilatation than larger individuals, so sex-specific thresholds should be considered during follow-up. 6

---

Summary Statement for Cardiovascular Specialists

This asymptomatic patient with grade 1 diastolic dysfunction, normal left atrial volume index (21 mL/m²), and normal E/e′ (9.2) does not meet diagnostic criteria for heart failure with preserved ejection fraction and is classified as ACC/AHA Stage B (structural heart disease without symptoms). The normal left atrial parameters are particularly reassuring and argue against clinically significant diastolic disease. The patient requires surveillance with annual echocardiography and biannual clinical assessment, can maintain normal activities without restriction, and should not receive heart failure pharmacotherapy at this time. The focus should be on cardiovascular risk factor modification, blood pressure optimization, and prompt evaluation if symptoms develop.